America Great Health (AAGH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Quarterly

0 70K 140K 210K Q4 '24: 95.7K Q1 '25: 140.1K Q2 '25: 90.9K Q3 '25: 56.1K Q4 '25: 104.5K Q1 '26: 187.6K Q2 '26: 45.1K Q3 '26: 26.1K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Gross Profit Quarterly

-50K 0 50K 100K 150K Q4 '24: -8.6K Q1 '25: 128.8K Q2 '25: 83.1K Q3 '25: 49.8K Q4 '25: 77.4K Q1 '26: 112.7K Q2 '26: 36.5K Q3 '26: 22.5K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating Income Quarterly

-450K -300K -150K 0 150K 300K 450K Q4 '24: -419.6K Q1 '25: -70.9K Q2 '25: -120.5K Q3 '25: -85.3K Q4 '25: -106.2K Q1 '26: -3.4K Q2 '26: -198.8K Q3 '26: -73.8K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Net Income Quarterly

-800K -400K 0 400K 800K 1.2M Q4 '24: -589.3K Q1 '25: -145.4K Q2 '25: -193.1K Q3 '25: -158.4K Q4 '25: -222.2K Q1 '26: -85.4K Q2 '26: 1.1M Q3 '26: -166K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Cost of Revenue Quarterly

0 40K 80K 120K Q4 '24: 104.3K Q1 '25: 11.3K Q2 '25: 7.8K Q3 '25: 6.3K Q4 '25: 27.1K Q1 '26: 74.9K Q2 '26: 8.6K Q3 '26: 3.6K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating Cash Flow Quarterly

-300K -200K -100K 0 100K 200K 300K Q4 '24: -165.4K Q1 '25: -95.6K Q2 '25: 88.8K Q3 '25: -53.5K Q4 '25: -272.6K Q1 '26: 44.5K Q2 '26: -126.5K Q3 '26: 1.7K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Free Cash Flow Quarterly

-300K -200K -100K 0 100K 200K 300K Q1 '23: -143.2K Q2 '23: -116.8K Q3 '23: -202.3K Q4 '23: 28.1K Q1 '24: -46.7K Q2 '24: -285K Q3 '24: -118.5K Q4 '24: -165.4K Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 8B 16B 24B Q2 '24: 21.1B Q3 '24: 21.1B Q1 '25: 21.1B Q2 '25: 21.1B Q3 '25: 21.2B Q1 '26: 21.2B Q2 '26: 21.2B Q3 '26: 21.2B Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '26: 0.00 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.